Stock Report

Krebs Biochemicals and Industries Ltd Q4FY22 loss at Rs. 11.31 crores

Posted On : 2022-05-23 15:23:56( TIMEZONE : IST )

Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 19.9503 crores during the period ended March 31, 2022 as compared to Rs. 22.0113 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. -11.3139 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -12.9409 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. -5.39 for the period ended March 31, 2022 as compared to Rs. -6 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 19.9503 crs	₹22.0113 crs	-9.36%
Net Profit	₹-11.3139 crs	₹-12.9409 crs	12.57%
EPS	₹-5.39	₹-6	10.17%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 19.9503 crores during the period ended March 31, 2022 as compared to Rs.16.3034 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.-11.3139 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-6.9866 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.-5.39 for the period ended March 31, 2022 as compared to Rs.-3.47 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 19.9503 crs	₹16.3034 crs	22.37%
Net Profit	₹-11.3139 crs	₹-6.9866 crs	61.94%
EPS	₹-5.39	₹-3.47	55.33%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.60.8589 crores during the Financial Year ended March 31, 2022 as compared to Rs.54.3217 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.-44.5268 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-28.3586 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.-20.81 for the Financial Year ended March 31, 2022 as compared to Rs.-14.37 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹60.8589 crs	₹54.3217 crs	12.03%
Net Profit	₹-44.5268 crs	₹-28.3586 crs	57.01%
EPS	₹-20.81	₹-14.37	44.82%

Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 129.40 as compared to the previous close of Rs. 122.50. The total number of shares traded during the day was 412 in over 21 trades.

The stock hit an intraday high of Rs. 129.80 and intraday low of 127.70. The net turnover during the day was Rs. 52975.00.